Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Optimizing classical hematology referrals: Development and early evaluation of an enhanced referral intervention

Ashley Price, Jacqueline Poston, Neil Zakai, Karlyn Martin

Blood (2025) 146 (Supplement 1): 6175.

https://doi.org/10.1182/blood-2025-6175

Published: 2025

Journal Articles

External validation of the intermountain risk scores for post-discharge (PD) thrombosis and bleeding in an independent population

Mansour Gergi, Katherine Wilkinson, Nicholas Roetker, Karlyn Martin, Allen Repp, Chris Holmes, Neil Zakai

Blood (2025) 146 (Supplement 1): 2684.

https://doi.org/10.1182/blood-2025-2684

Published: 2025

Journal Articles

Thrombotic and hemorrhagic events and their impact on mortality among adults with newly diagnosed acute myeloid leukemia

Diego Adrianzen Herrera, Andrew Sparks, Radhika Gangaraju, Karlyn Martin, Mansour Gergi, Katherine Wilkinson, Chris Holmes, Pamela Lutsey, Aditi Shastri, Neil Zakai

Blood (2025) 146 (Supplement 1): 2682.

https://doi.org/10.1182/blood-2025-2682

Published: 2025

Journal Articles

Clonal hematopoiesis and risk of mortality after incident ischemic stroke: The reasons for geographic and racial differences in stroke Study

Radhika Gangaraju, Yanjun Chen, Alexander Bick, Ryan Packer, Caitlyn Vlasschaert, Nicole Armstrong, Joshua Richman, Mary Cushman, Marguerite Irvin, Neil Zakai, Smita Bhatia

Blood (2025) 146 (Supplement 1): 4941.

https://doi.org/10.1182/blood-2025-4941

Published: 2025

Journal Articles

Development and validation of a risk assessment model for inpatient venous thrombosis in people with cancer

Karlyn Martin, Katherine Wilkinson, Andrew Sparks, Nicholas Roetker, Mansour Gergi, Diego Adrianzen Herrara, Jordan Schaefer, Ang Li, Radhika Gangaraju, Brian Sprague, Chris Holmes, Neil Zakai

Blood (2025) 146 (Supplement 1): 20.

https://doi.org/10.1182/blood-2025-20

Published: 2025

Journal Articles

Disseminated Intravascular Coagulation and Early Thrombo-Hemorrhagic Complications in Acute Promyelocytic Leukemia

Ella Johnson, Karan Bansal, Chen Dai, Wajiha Mekki, Sindhu Dwarampudi, Lindsey Hageman, Joshua Knapp, Pankit Vachhani, Ravi Bhatia, Yohei Hisada, Neil Zakai, Smita Bhatia, Radhika Gangaraju

Blood (2024) 144 (Supplement 1): 3796.

https://doi.org/10.1182/blood-2024-203729

Published: 2024

Journal Articles

Erythropoietin Stimulating Agents and Risk of Cardiovascular Events in Older Patients with Myelodysplastic Syndromes

Diego Adrianzen Herrera, Andrew Sparks, Aneta Strumilowska, Neil Zakai

Blood (2024) 144 (Supplement 1): 5180.

https://doi.org/10.1182/blood-2024-210918

Published: 2024

Journal Articles

Risk Factors for Bleeding after Recent Medical Hospitalization: The Medical Inpatient Thrombosis and Hemostasis Study (MITH)

Mansour Gergi, Katherine Wilkinson, Andrew Sparks, Nicholas S Roetker, Hanny Al-Samkari, Nicholas L Smith, Timothy B Plante, Mary Cushman, Allen B Repp, Chris E. Holmes, Karlyn A. Martin, Neil Zakai

Blood (2024) 144 (Supplement 1): 2252.

https://doi.org/10.1182/blood-2024-201581

Published: 2024

Journal Articles

Impact of Thrombosis and Bleeding on Survival of Older People with Myelodysplastic Syndromes (MDS): A Population Analysis

Mansour Gergi, Andrew Sparks, Neil Zakai, Diego Adrianzen Herrera

Blood (2024) 144 (Supplement 1): 702.

https://doi.org/10.1182/blood-2024-205784

Published: 2024

Journal Articles

Impact of Hospital-Acquired Venous Thromboembolism on Surviving Medical Admission: Findings from the Medical Inpatient Thrombosis and Hemostasis Study

Karlyn A. Martin, Andrew Sparks, Katherine Wilkinson, Ryan Packer, Deirdra R Terrell, Mansour Gergi, Augusto Ferraris, William A. Wood, Allen B Repp, Nicholas S Roetker, Neil Zakai

Blood (2024) 144 (Supplement 1): 3704.

https://doi.org/10.1182/blood-2024-207263

Published: 2024

Journal Articles

Impact of Cancer Diagnosis on Appropriate Use of Antithrombotic Medications in Individuals with Cardiovascular Diseases

Mansour Gergi, Katherine Wilkinson, Diego Adrianzen Herrera, Chris E. Holmes, Neil Zakai

Blood (2023) 142 (Supplement 1): 5070.

https://doi.org/10.1182/blood-2023-189281

Published: 2023

Journal Articles

Impact of Hypomethylating Agents on Cardiovascular Disease Risk Among Patients with Myelodysplastic Syndromes

Diego Adrianzen Herrera, Andrew Sparks, Mansour Gergi, Katherine Giorgio, Pamela Lutsey, Neil Zakai

Blood (2023) 142 (Supplement 1): 549.

https://doi.org/10.1182/blood-2023-185407

Published: 2023

Journal Articles

Utilization Patterns and Outcomes from Iron Chelation in Elderly Patients with Low-Risk Myelodysplastic Syndrome

Diego Adrianzen Herrera, Andrew Sparks, Rohit Singh, Katherine Giorgio, Pamela Lutsey, Neil Zakai

Blood (2023) 142 (Supplement 1): 914.

https://doi.org/10.1182/blood-2023-185376

Published: 2023

Journal Articles

Bleeding Risk from Anticoagulant Thromboprophylaxis in Patients with Multiple Myeloma

Diego Adrianzen Herrera, Katherine Giorgio, Rob Walker, Andrew Sparks, Mansour Gergi, Neil Zakai, Pamela Lutsey

Blood (2023) 142 (Supplement 1): 2369.

https://doi.org/10.1182/blood-2023-185339

Published: 2023

Journal Articles

Metabolic Syndrome Among Patients with Myelodysplastic Syndrome: A Population Analysis

Akshee Batra, Andrew Sparks, Rohit Singh, Atulya Aman Khosla, Neil Zakai, Diego Adrianzen Herrera

Blood (2023) 142 (Supplement 1): 3805.

https://doi.org/10.1182/blood-2023-187472

Published: 2023

Journal Articles

Fatigue and Cognition During Remission in Adults with Immune Thrombotic Thrombocytopenic Purpura

Shannon M Reeves, Amanda J Llaneza, Sara K. Vesely, Janna Journeycake, Mohamad O. Khawandanah, Marshall Mazepa, Frank Akwaa, Adam Cuker, Shruti Chaturvedi, Neil Zakai, Ming Yeong Lim, Radhika Gangaraju, San Keller, Spero Cataland, Deirdra R Terrell

Blood (2022) 140 (Supplement 1): 1228–1229.

https://doi.org/10.1182/blood-2022-170139

Published: 2022

Journal Articles

Effects of Autoimmune Disease on Non-High Risk MDS Outcomes: A Population Analysis

Rohit Singh, David Alfonso Alejos Castillo, Akshee Batra, Andrew D Sparks, Aditi Shastri, Kith Pradhan, Neil Zakai, Diego Adrianzen Herrera

Blood (2022) 140 (Supplement 1): 692–693.

https://doi.org/10.1182/blood-2022-163522

Published: 2022

Journal Articles

Venous Thromboembolism Risk in Cancer Patients Receiving First-Line Immune Checkpoint Inhibitor Vs. Chemotherapy

Sarah B May, Jennifer La, Emily Milner, Nimrah Riaz, Christopher I Amos, David A. Garcia, Marc Carrier, Neil Zakai, Nhan V Do, Mary Brophy, Vipul Chitalia, J. Michael Gaziano, Nathanael Fillmore, Ang Li

Blood (2022) 140 (Supplement 1): 7968–7970.

https://doi.org/10.1182/blood-2022-162658

Published: 2022

Journal Articles

Derivation and External Validation of Clinical Risk Assessment Model for Cancer Associated Thrombosis in Two Unique U.S. Healthcare Systems

Ang Li, Jennifer La, Sarah B May, Danielle Guffey, Wilson L Da Costa, Jr., Christopher I Amos, Emily Milner, Raka Bandyo, Carolina Granada, Nimrah Riaz, Nhan V Do, Mary Brophy, Vipul Chitalia, J. Michael Gaziano, David A. Garcia, Marc Carrier, Christopher R. Flowers, Neil Zakai, Nathanael Fillmore

Blood (2022) 140 (Supplement 1): 5637–5639.

https://doi.org/10.1182/blood-2022-160017

Published: 2022

Journal Articles

Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWF

Jennifer E. Huffman, Paul S. de Vries, Alanna C. Morrison, Maria Sabater-Lleal, Tim Kacprowski, Paul L. Auer, Jennifer A. Brody, Daniel I. Chasman, Ming-Huei Chen, Xiuqing Guo, Li-An Lin, Riccardo E. Marioni, Martina Müller-Nurasyid, Lisa R. Yanek, Nathan Pankratz, Megan L. Grove, Moniek P. M. de Maat, Mary Cushman, Kerri L. Wiggins, Lihong Qi, Bengt Sennblad, Sarah E. Harris, Ozren Polasek, Helene Riess, Fernando Rivadeneira, Lynda M. Rose, Anuj Goel, Kent D. Taylor, Alexander Teumer, André G. Uitterlinden, Dhananjay Vaidya, Jie Yao, Weihong Tang, Daniel Levy, Melanie Waldenberger, Diane M. Becker, Aaron R. Folsom, Franco Giulianini, Andreas Greinacher, Albert Hofman, Chiang-Ching Huang, Charles Kooperberg, Angela Silveira, John M. Starr, Konstantin Strauch, Rona J. Strawbridge, Alan F. Wright, Barbara McKnight, Oscar H. Franco, Neil Zakai, Rasika A. Mathias, Bruce M. Psaty, Paul M. Ridker, Geoffrey H. Tofler, Uwe Völker, Hugh Watkins, Myriam Fornage, Anders Hamsten, Ian J. Deary, Eric Boerwinkle, Wolfgang Koenig, Jerome I. Rotter, Caroline Hayward, Abbas Dehghan, Alex P. Reiner, Christopher J. O’Donnell, Nicholas L. Smith

Blood (2015) 126 (11): e19–e29.

https://doi.org/10.1182/blood-2015-02-624551

Published: 2015

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Optimizing classical hematology referrals: Development and early evaluation of an enhanced referral intervention

External validation of the intermountain risk scores for post-discharge (PD) thrombosis and bleeding in an independent population

Thrombotic and hemorrhagic events and their impact on mortality among adults with newly diagnosed acute myeloid leukemia

Clonal hematopoiesis and risk of mortality after incident ischemic stroke: The reasons for geographic and racial differences in stroke Study

Development and validation of a risk assessment model for inpatient venous thrombosis in people with cancer

Disseminated Intravascular Coagulation and Early Thrombo-Hemorrhagic Complications in Acute Promyelocytic Leukemia

Erythropoietin Stimulating Agents and Risk of Cardiovascular Events in Older Patients with Myelodysplastic Syndromes

Risk Factors for Bleeding after Recent Medical Hospitalization: The Medical Inpatient Thrombosis and Hemostasis Study (MITH)

Impact of Thrombosis and Bleeding on Survival of Older People with Myelodysplastic Syndromes (MDS): A Population Analysis

Impact of Hospital-Acquired Venous Thromboembolism on Surviving Medical Admission: Findings from the Medical Inpatient Thrombosis and Hemostasis Study

Impact of Cancer Diagnosis on Appropriate Use of Antithrombotic Medications in Individuals with Cardiovascular Diseases

Impact of Hypomethylating Agents on Cardiovascular Disease Risk Among Patients with Myelodysplastic Syndromes

Utilization Patterns and Outcomes from Iron Chelation in Elderly Patients with Low-Risk Myelodysplastic Syndrome

Bleeding Risk from Anticoagulant Thromboprophylaxis in Patients with Multiple Myeloma

Metabolic Syndrome Among Patients with Myelodysplastic Syndrome: A Population Analysis

Fatigue and Cognition During Remission in Adults with Immune Thrombotic Thrombocytopenic Purpura

Effects of Autoimmune Disease on Non-High Risk MDS Outcomes: A Population Analysis

Venous Thromboembolism Risk in Cancer Patients Receiving First-Line Immune Checkpoint Inhibitor Vs. Chemotherapy

Derivation and External Validation of Clinical Risk Assessment Model for Cancer Associated Thrombosis in Two Unique U.S. Healthcare Systems

Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWF

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only